Xtx Topco LTD Cyma Bay Therapeutics, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.63 - $24.47 $98,627 - $191,086	-7,809 Reduced 42.04%	10,767 $254,000
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $201,735 - $327,309	18,576 New	18,576 $276,000
Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.39 $29,893 - $58,918	17,380 Added 101.15%	34,563 $102,000
Q1 2022 May 13, 2022	BUY	$2.77 - $3.64 $47,596 - $62,546	17,183 New	17,183 $53,000
Q3 2021 Nov 12, 2021	SELL	$3.47 - $4.42 $116,793 - $148,768	-33,658 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.94 - $4.92 $56,267 - $70,262	14,281 Added 73.7%	33,658 $147,000
Q1 2021 May 14, 2021	BUY	$4.23 - $6.55 $81,964 - $126,919	19,377 New	19,377 $88,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.